Endpoints: ARCH unveils its Really Big Neuroscience Company with $500M, an Amgen deal and eyes on depression, Alzheimer’s and a lot more Read more https://endpts.com/arch-unveils-its-really-big-neuroscience-company-with-500m-an-amgen-deal-and-eyes-on-depression-alzheimers-and-a-lot-more/
